 | |
| Company type | Public |
|---|---|
| BSE: 539523 NSE: ALKEM | |
| Industry | Pharmaceuticals |
| Founded | 1973; 52 years ago (1973) |
| Founder | Samprada Singh |
| Headquarters | , India |
Key people |
|
| Products | |
| Revenue |  ₹12,964 crore (US$1.5 billion) (2025) |
| ₹2,512 crore (US$300 million) (2025) | |
| ₹2,165 crore (US$260 million) (2025) | |
| Total assets | ₹17,691 crore (US$2.1 billion) (2025) |
| Total equity | ₹12,433 crore (US$1.5 billion) (2025) |
Number of employees | 20,000 (2024)[2] |
| Subsidiaries | Pharmacor Limited, Ascend, Cachet, Enzene, Indchemie, Connect2clinic, Alkem Foundation[3] |
| Website | www |
| Footnotes / references Financials as of 31 March 2025[update].[4][5] | |
Alkem Laboratories Limited is an Indian multinationalpharmaceutical company headquartered inMumbai. Specialising ingenerics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics,formulations andnutraceuticals across India and global markets.
Samprada Singh was the founder and chairman emeritus of the company; he had aB.Com degree fromPatna University. His brother, Basudeo Narayan Singh, was also the co-founder of the company.[6]
Alkem set up its research and development facility forANDA development atTaloja in 2003.[7] In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India.[8] In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.
In 2007 the company filed its first ANDA for drugAmlodipine which was approved in 2009.[7] Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are USFDA,TGA, UKMHRA approved.
Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[9] In 2018, he was the 46th richest person in India.[10]
Alkem has 21 manufacturing facilities: 19 in India and 2 in the US.[11] These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India fromGalderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.[12]
  | This article about an Indian company is astub. You can help Wikipedia byexpanding it. |
